Clinical Trial Update: Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating patient performance with the Metoject subcutaneous injection device in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Metoject (methotrexate)

Snippet

Sponsor: medac GmbH | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: COMPLETED